Cyber Monday Deal: Up to 60% off InvestingProCLAIM SALE

Italy's first Ebola patient is stable and being treated in Rome

Published 25/11/2014, 13:47
© Reuters. Doctor Emanuele Nicastri speaks during a news conference at the Spallanzani hospital in Rome

By Isla Binnie

ROME (Reuters) - Italy's first Ebola patient is in stable condition in Rome after arriving on Tuesday from Sierra Leone where he contracted the disease while treating the sick there, his doctor said.

The man, a 50-year-old Sicilian doctor whose name was not given, was working for the Italian humanitarian organisation Emergency in one of the countries hardest hit by the virus.

He will be treated with an experimental drug administered to other Ebola patients in Europe and the United States, but which has never been used in Italy before, said Dr Emanuele Nicastri, who did not name the drug.

The patient was running a fever but "is alert, collaborative and can walk," Nicastri told reporters at the Lazzaro Spallanzani infectious diseases institute in Rome.

Ebola has killed around a third of more than 15,000 confirmed sufferers in its worst epidemic to date.

Italy's air force, which brought the infected doctor back from West Africa, said earlier on Tuesday the trip had gone according to plan and he had been "calm the whole way".

Almost all cases of Ebola identified since the virus was first detected in the jungles of southeast Guinea in March have been in Guinea, Sierra Leone and Liberia.

© Reuters. Doctor Emanuele Nicastri speaks during a news conference at the Spallanzani hospital in Rome

The United Nations warned on Monday it would not meet its overall target of containing the virus by Dec. 1 because of rising cases in Sierra Leone, but said it would meet or exceed the target in other areas.

(Additional reporting by Gavin Jones; Editing by Steve Scherer and Tom Heneghan)

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.